非奈利酮在2型糖尿病合并慢性肾病治疗中的应用进展  

Application of Finelidone in the Treatment of Type 2 Diabetes Mellitus Complicated with Chronic Kidney Disease

作　　者：赵东坤[1] ZHAO Dongkun(Department of Drug Dispensing,Zibo Central Hospital,Zibo,Shandong Province,255036 China)

机构地区：[1]淄博市中心医院药品调剂科,山东淄博255036

出　　处：《糖尿病新世界》2023年第18期187-189,194,共4页Diabetes New World Magazine

摘　　要：2型糖尿病合并慢性肾病(diabetic nephropathy,DN)患病率高、危害性大,以慢性白蛋白尿和肾小球滤过障碍为主。非奈利酮是目前临床上最常用的一种醛固酮受体阻断药,也是临床上最常用的一种药物,另外常用药还有:依普利酮、螺内酯等。本次研究主要针对非奈利酮在2型糖尿病合并慢性肾病治疗中的应用进展进行分析。Type 2 diabetes mellitus complicated with chronic nephropathy(DN)is a dangerous disease with high prevalence,mainly chronic albuminuria and glomerular filtration disorders.Fenelidone is currently the most commonly used aldosterone receptor blocker in clinical practice,and is also the most commonly used drug in clinical practice.In addition,commonly used drugs include epinephrine,spironolactone.In this study,the application of finelidone in the treatment of type 2 diabetes mellitus combined with chronic kidney disease was analyzed.

关 键 词：非奈利酮 2型糖尿病 慢性肾病 治疗 

分 类 号：R4[医药卫生—临床医学]